Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

Jens F. Rehfeld; Filip K. Knop; Ali Asmar; Sten Madsbad; Jens J. Holst; Meena Asmar

doi:10.1080/00365521.2018.1530297

Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

Jens F. Rehfeld, Filip K. Knop, Ali Asmar, Sten Madsbad, Jens J. Holst, Meena Asmar

Institut for Klinisk Medicin

7 Citationer (Scopus)

Originalsprog	Engelsk
Bogserie	Scandinavian Journal of Gastroenterology
Vol/bind	53
Udgave nummer	12
Sider (fra-til)	1429-1432
ISSN	0036-5521
DOI	https://doi.org/10.1080/00365521.2018.1530297
Status	Udgivet - 2 dec. 2018

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1080/00365521.2018.1530297

Citationsformater

Cholecystokinin secretion is suppressed by glucagon-like peptide-1 : clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs. / Rehfeld, Jens F.; Knop, Filip K.; Asmar, Ali et al.

I: Scandinavian Journal of Gastroenterology, Bind 53, Nr. 12, 02.12.2018, s. 1429-1432.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{9090b7ad4e7c4499a84bc4b27219d2ed,

title = "Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs",

keywords = "Cholecystokinin, cholecystitis, cholelithiasis, diabetes mellitus, glucagon-like peptide 1, side effects",

author = "Rehfeld, {Jens F.} and Knop, {Filip K.} and Ali Asmar and Sten Madsbad and Holst, {Jens J.} and Meena Asmar",

year = "2018",

month = dec,

day = "2",

doi = "10.1080/00365521.2018.1530297",

language = "English",

volume = "53",

pages = "1429--1432",

journal = "Scandinavian Journal of Gastroenterology. Supplement",

issn = "0085-5928",

publisher = "Taylor & Francis",

number = "12",

}

TY - JOUR

T1 - Cholecystokinin secretion is suppressed by glucagon-like peptide-1

T2 - clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

AU - Rehfeld, Jens F.

AU - Knop, Filip K.

AU - Asmar, Ali

AU - Madsbad, Sten

AU - Holst, Jens J.

AU - Asmar, Meena

PY - 2018/12/2

Y1 - 2018/12/2

KW - Cholecystokinin

KW - cholecystitis

KW - cholelithiasis

KW - diabetes mellitus

KW - glucagon-like peptide 1

KW - side effects

U2 - 10.1080/00365521.2018.1530297

DO - 10.1080/00365521.2018.1530297

M3 - Journal article

C2 - 30449207

SN - 0085-5928

VL - 53

SP - 1429

EP - 1432

JO - Scandinavian Journal of Gastroenterology. Supplement

JF - Scandinavian Journal of Gastroenterology. Supplement

IS - 12

ER -

Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater